Articles

OTE and Dr Jorge Alió provide a glimpse of some of the scientific sessions and courses not to be missed at this year’s congress of the ESCRS. We also provide you with some tips on how to make the most out of your stay in Berlin.

With diabetes cases worldwide expected to double in the first 30 years of the 21st century, telemedicine might be a pathway to ensuring that more patients receive care, and thus, prevent complications from retinopathy.

News In Focus for July and August 2008

Dr John Nolan discusses the crucial role of the macular carotenoids in the prevention of this blinding disease.

New investigative drugs for age-related macular degeneration (AMD) may complement the vascular endothelial growth factor (VEGF) agents, improve the visual results, and require fewer injections. Various routes of administration are under investigation and combination treatments are likely to provide more favourable results.

Assistant Professor Alexis Tsorbatzoglou and Professor Andras Berta discuss the various theories presented to define the mechanism of accommodation.

Achieving the proper IOL power for patients who have had a refractive procedure such as LASIK, PRK, or RK can be challenging, and taking more measurements leads to greater accuracy.

Using various types of IOLs in the same patient has been trumpeted as a way to achieve better vision correction than bilaterally implanting the same IOL. Yet, this concept of "mix and match" is not quite that simple.

Microneedles offer a better method of ocular drug delivery than traditional methods, according to research presented during the Ophthalmic Drug Delivery symposium, held on June 30 at a meeting of the Royal Pharmaceutical Society of Great Britain.

Following disappointing clinical trial results, Alcon has discontinued its plans to develop anecortave acetate for the prevention of choroidal neovascularization secondary to age-related macular degeneration (AMD).

WebAnywhere, a new web tool that allows the blind to surf the web "on the go", without any additional software or installation requirements, has been launched.

Dorairajan Balasubramanian, director of research, L.V. Prasad Eye Institute, Hyderabad, India, reported on in vitro tests he has performed on cells and polyphenols such as epigallocatechin gallate (ECGC) and catechin, and their protective value against cytotoxic agents.

Dr Perry Binder discusses advances in femtosecond technology that are taking us a step closer to the ideal.

The rising demand for presbyopia-correcting IOLs has led to a rise in patient expectations, but can we please everyone? questions Professor Jay Pepose.

There is much to be learned about nocturnal-and, more importantly, sleeping-IOP if ophthalmologists are going to optimize glaucoma therapies, said Yaniv Barkana, MD, Department of Ophthalmology, Assaf Harofeh Medical Center, Israel.

A combination of procedures could be best option for some patients, claims Dr Volker Rasch.

Should glaucoma drainage devices still be viewed as the last resort? asks Professor Walter Konen.

This technique, using a femtosecond laser, has been shown to improve ?near vision in presbyopes, according to Dr Luis Antonio Ruiz.

Highlights from the World Ophthalmology Congress 2008.

Highlights from the 2008 WOC meeting, held June 28–July 2 in Hong Kong

Is there a place for traditional Chinese medicine in modern ophthalmology? Quite possibly, said Dennis Lam, MD, FRCS, Chinese University of Hong Kong.

Transplants of foetal retinal cells are an effective treatment for retinal degeneration involving the destruction of photoreceptor cells, according to a report published in the August 2008 issue of the American Journal of Ophthalmology.

Live animal testing for ocular safety in the US is to be replaced with bovine corneal opacity and permeability (BCOP) and isolated chicken eye (ICE) assays, which do not involve the use of live animals. These alternative tests are scientifically valid and have acceptance as testing methods from regulatory agencies the Food and Drug Administration (FDA) and the Consumer Product Safety Commission (CPSC).

A guide to getting the most out of your stay in Berlin

Dr Josef Reiter describes his reasons for increasing his number of Epi-LASIK procedures.

Light sensors present in 2% of retinal cells relate to the body's internal clock and not to vision, according to research published in the journal PLoS ONE.

A lamellar sliver is a devastating complication resulting from recutting flaps during LASIK enhancement procedures.

An intellectual property database has already revealed great insights into R&D, and it opens up a whole new world of information, according to Dr Hermann Mucke.

The use of an artificial cornea in patients who have experienced multiple immunologic graft rejections is more likely to result in good-quality vision than is performing another corneal transplant.

Intraoperative floppy iris syndrome (IFIS) can be approached in a number of ways depending on the surgical scenario, according to David Chang, MD, University of California, San Francisco.